Skip to main content
logo
Aarey Drugs & Pharmaceuticals Limited (NSE:AAREYDRUGS)
India flag India · Delayed Price · Currency is INR
101.00
-1.63 (-1.59%)
Sep 24, 2026, 3:29 PM IST

NSE:AAREYDRUGS Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
4,1474,7234,7394,0264,1904,929
Revenue Growth
-7.69%-0.35%17.73%-3.91%-15.01%40.27%
Gross Profit
158.61176.75118.23206.4150.87208.51
Operating Income
35.857.8151.1797.7166.92100.27
Net Income
36.239.6840.2446.8437.7165.55
Earnings Per Share
1.271.391.411.841.482.72
EPS Growth
-13.95%-1.42%-23.37%24.32%-45.59%-2.36%

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
33.9833.9832.2928.911.241.92
Total Debt
607.49582.93435.49313.52377.18141.63
Net Cash (Debt)
-573.51-548.95-403.2-284.63-365.94-139.71
Net Cash Growth
------
Net Cash Per Share
-20.16-19.29-14.17-11.20-14.36-5.80

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
-101.39103-29.94-12.814.99
Capital Expenditures
--124.11-52.04-7.22-10.44-22.01
Free Cash Flow
--22.7250.96-37.16-23.25-17.03
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
3.82%3.74%2.50%5.13%3.60%4.23%
Operating Margin
0.86%1.22%1.08%2.43%1.60%2.03%
Pretax Margin
1.01%1.15%1.29%1.33%1.43%2.04%
Profit Margin
0.87%0.84%0.85%1.16%0.90%1.33%
FCF Margin
--0.48%1.07%-0.92%-0.56%-0.34%

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
80.1936.4923.4226.7615.9316.03
P/FCF Ratio
--18.49---
PS Ratio
0.700.310.200.310.140.21